April 25, 2008

Pfizer enters deal to acquire Schering-Plough animal health products

Press release

Pfizer Animal Health announced that it has entered into an agreement to acquire multiple product franchises from Schering-Plough Corp covering all major animal health species including cattle and swine.

Specifically, Pfizer Animal Health will acquire from Schering-Plough a number of animal health products for sale in the European Economic Area covering vaccines for swine E. coli vaccines, ruminant neonatal, clostridia, and rabies.

The acquisition is subject to certain closing conditions, including antitrust approval. Terms of the agreement were not disclosed.

Pfizer Animal Health's Europe President, Albert Bourla, said that the acquisition would enable Pfizer Animal Health Europe to build upon its comprehensive animal health solutions for veterinarians and their clients in Europe.

Pfizer Inc, the world's largest research-based pharmaceutical company, is a world leader in discovering and developing innovative animal vaccines and prescription medicines.